Results 41 to 50 of about 8,911,089 (208)

Major adverse cardiovascular events of the patients followed-up.

, 2013
Major adverse cardiovascular events of the patients followed-up.
Naifeng Liu (311606), Yi Feng (29944), Yang Li (7082), Yanan Ji (345237), Chengxing Shen (311601), Genshan Ma (150359)   +5 more
core   +1 more source

Efficacy, retention, and safety of baricitinib in real-life: HUR-BIO monocentric experience

Ulusal Romatoloji Dergisi
Objective: This study evaluates the effectiveness, retention rate and safety of baricitinib, including a comparison between baricitinib and a tumour necrosis factor inhibitor (adalimumab) in a real-life cohort of patients with rheumatoid arthritis (RA).
Mustafa Ekici, İrem Yıldız İçli, Ece Ersal Deregözü, Emre Bilgin, Zehra Özsoy, Gizem Ayan, Gül Sandal Uzun, Erdinç Ünaldı, Büşra Fırlatan Yazgan, Gözde Sevgi Kart Bayram, Buğu Bulat, Levent Kılıç, Ali Akdoğan, Şule A. Bilgen, Sedat Kiraz, İhsan Ertenli   +15 more
doaj   +1 more source

Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease

Journal of Parkinson’s Disease, 2020
Background: Parkinson’s disease and cardiovascular disease are highly prevalent conditions in the elderly. Evidence shows inconsistent findings regarding the association between Parkinson’s disease and cardiovascular events.
Mariana Alves, Daniel Caldeira, Miguel Leal Rato, Gonçalo S. Duarte, Afonso N. Ferreira, José Ferro, Joaquim J. Ferreira   +6 more
doaj   +1 more source

Blood pressure and the risk of major adverse cardiovascular events among firefighters

Journal of Hypertension, 2020
Objective: No long-term follow-up study has investigated the effect of blood pressure (BP) on cardiovascular disease mortality and morbidity in firefighters. To investigate the effects of BP on the risk of major adverse cardiovascular events (MACEs) using a national representative population-matched cohort.
Juhwan, Noh, Chan Joo, Lee, Dae-Sung, Hyun, Woojin, Kim, Mi-Ji, Kim, Ki-Soo, Park, Sangbaek, Koh, Sei-Jin, Chang, Changsoo, Kim, Sungha, Park   +9 more
openaire   +3 more sources

Univariate Cox analysis for major adverse cardiovascular events.

, 2015
HR, hazard ratio; CI, confidence interval.Univariate Cox analysis for major adverse cardiovascular events.
Jiaojiao Xu (813939), Dongyu Xia (813940), Yu Xiang (261980), Lan Mi (813938), Na Zhao (112953), Zhongwei Liu (723226), Yong Zhang (5893), Zuyi Yuan (143452), Gongchang Guan (813941), Shuo Pan (583102), Xiaojun Liu (58952), Junkui Wang (813942)   +11 more
core   +1 more source

Risk of Major Adverse Cardiovascular Events Following Nicotinamide Exposure

JAMA Dermatology
ImportanceNicotinamide metabolites have recently been implicated in increased risk of major cardiovascular events (MACE). Supportive data about clinical risk of MACE for nicotinamide users is lacking.ObjectiveTo determine whether nicotinamide use results in an increase of MACE.Design, Setting, and ParticipantsThis study used retrospective electronic ...
Lee Wheless, Ranya Guennoun, Basia Michalski-McNeely, Katlyn M. Gonzalez, Rachel Weiss, Siwei Zhang, Lydia Yao, Chris Madden, Hua-Chang Chen, Jefferson L. Triozzi, Ran Tao, Otis Wilson, Quinn S. Wells, Adriana Hung, Kristin Bibee, Rebecca I. Hartman, Yaomin Xu, Sumitra Muralidhar, Jennifer Moser, Jennifer E Deen, Philip S Tsao, J. Michael Gaziano, Elizabeth Hauser, Amy Kilbourne, Michael Matheny, Dave Oslin, Deepak Voora, Jessica V Brewer, Mary T Brophy, Kelly Cho, Lori Churby, Scott L DuVall, Saiju Pyarajan, Robert Ringer, Luis E Selva, Shahpoor (Alex) Shayan, Brady Stephens, Stacey B Whitbourne, Themistocles L Assimes, Adriana Hung, Henry Kranzler   +40 more
openaire   +3 more sources

Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Improvement in left ventricular ejection fraction (LVEF) aligns with better outcomes in patients with heart failure with reduced EF. Nonetheless, detailed relationship between the extent of LVEF improvement and the risks of adverse cardiorenal
Cheng‐Chien Lai, Shao‐Sung Huang, Ya‐Wen Lu, Chung‐Kuan Wu, Yi‐Hong Wu, Wei‐Cheng Tseng   +5 more
doaj   +1 more source

Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke"

, 2016
Comment on Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. [Int J Cardiol.
PASTORI, DANIELE, PIGNATELLI, Pasquale, BARILLA', Francesco, Lip, Gregory Y. H, VICARIO, TOMMASA, SALIOLA, Mirella, VIOLI, Francesco, CARNEVALE, Roberto, CANGEMI, ROBERTO   +8 more
core   +1 more source

Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors [PDF]

, 2023
Background: Acute kidney injury commonly occurs in patients admitted to ICU. After acute kidney injury, kidney function may not completely recover leading to increased risk of future cardiovascular events.
Traynor, Jamie P., Puxty, Kathryn A., Mark, Patrick B., Andonovic, Mark, Shaw, Martin, Curle, Jennifer, Sim, Malcolm A.B.   +6 more
core   +1 more source

The relation between tirzepatide and adverse cardiovascular events or renal adverse events: a meta-analysis based on randomized controlled trials

Diabetology & Metabolic Syndrome
Background This meta-analysis aimed to evaluate the relation between tirzepatide exposure and the risk of adverse cardiovascular or renal events in participants with type 2 diabetes mellitus (T2DM) or obesity. Methods A comprehensive search was conducted
Lishen Liu, Jingqi Chen, Xiaoming Zhang, Sidong Zhu, Tianfu Dai, Qingping Wu, Yinchao Fang   +6 more
doaj   +1 more source